The Snowdome Foundation and passionate volunteer, Geoff Nyssen were honoured at the 2022 Third Sector Awards, a national award celebrating and recognising the best not-for-profit practices around Australia. Winning the Small Charity of the Year and Volunteer of the Year Awards is a significant recognition of the passion and commitment of all within Snowdome and … Continued
June 30, 2022 Snowdome Foundation is very proud to have supported the global Women in Lymphoma (WiL) initiative since establishment in October 2020. Snowdome – having delivered on its promise to lend administrative and governance support to WiL, enabling them to greatly expand over the past 18 months – is very pleased to announce WiL’s … Continued
Snowdome is very proud to continue our collaboration with the prestigious Leukemia & Lymphoma Society USA and Australia’s Leukaemia Foundation to fund Australian researchers and clinicians specialising in blood cancer research. Now entering our fourth year of funding, we are delighted to announce funding for two more ground-breaking projects into treating paediatric leukaemia and CAR … Continued
Alastair Evans set out to honour his mother, Sally, aiming to raise $75,000 for blood cancer research, through a fundraising event called The Positive Journey – a four-day 270km run from Melbourne to Echuca, his hometown. Joining with friends, family and donors, Alastair raised over $150,000, running the equivalent of six marathons. The funds raised … Continued
In our special Blood, Sweat and Tears of Joy event held in May we heard stories of the impact blood cancer had on four special members of the Snowdome family – Karen Frenkiel, Brenda Cherednichenko, Geoff Nyseen and Alastair Evans. From the heartbreak of being diagnosed just days after becoming a mother, to a personal … Continued
We are very pleased to announce that Snowdome, in conjunction with the Leukaemia Foundation, are funding RAVEN, a new, national paediatric trial for Australian children with relapsed or refractory acute lymphoblastic leukaemia (ALL). This is the first study of its kind to look at the effectiveness of a combination treatment to overcome chemotherapy resistance in … Continued
In 2010 chimeric antigen receptor T-cell (CAR T-cell) therapy was very experimental. It had only been tested in mice but two gentlemen who had nothing to lose opted for the experimental treatment. Remarkably the treatment worked and proved to be their cure from chronic lymphocytic leukaemia (CLL). A study that followed the two CLL patients … Continued
The results of ELARA, a large international trial investigating the treatment of relapsed or refractory follicular lymphoma (FL) with chimeric antigen receptor T-cell therapy (CART-cell) tisagenlecleucel have been published. A remarkable 69.1 per cent of patients treated with tisagenlecleucel had a complete response (no detectable disease) to treatment. Overall, 86.2 per cent of treated patients … Continued
The Wilson family has extended their generous philanthropic donation to the Snowdome Foundation, providing an additional $3.5 million for the Wilson Centre for Blood Cancer Genomics housed at the Peter MacCallum Cancer Centre. This is the philanthropic family’s second major gift. In 2017, The Wilsons announced a major gift of $5.5 million to establish the Centre. The Wilson family have now donated more than $9 million to the Snowdome … Continued